Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03347292
Title Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Age Groups: adult | senior
Covered Countries USA | DEU

Facility Status City State Zip Country Details
USC Norris Hospital and Clinics Los Angeles California 90033 United States Details
University of Florida Health Sciences Center Gainesville Florida 32610-0286 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109-1023 United States Details
Universitätsklinikum Köln Köln Nordrhein-Westfalen 50937 Germany Details
Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz Rheinland-Pfalz 55131 Germany Details
*Shaded cells indicate that there was no data available from for the field